Developing new treatments for Alzheimer's disease
Medicinal Chemistry and Chemical Biology Core (MCCB)
['FUNDING_OTHER'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-10950444
This study is working on new tools and treatments for Alzheimer's disease to help improve the lives of patients by exploring fresh ideas beyond the usual methods, with a team of experts from Indiana University and Purdue University collaborating to find better solutions.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INDIANA UNIVERSITY INDIANAPOLIS (nih funded) |
| Locations | 1 site (INDIANAPOLIS, UNITED STATES) |
| Trial ID | NIH-10950444 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative tools and therapies for Alzheimer's disease by integrating advanced drug discovery techniques and disease biology. The team at Indiana University and Purdue University aims to develop Target Enabling Packages (TEPs) that explore new hypotheses related to Alzheimer's, moving beyond traditional amyloid beta approaches. Patients may benefit from the development of new medications and treatment strategies that could improve their quality of life. The research involves collaboration among various experts to ensure a comprehensive approach to tackling this complex disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for Alzheimer's disease, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promise in developing new therapeutic approaches for Alzheimer's disease, indicating that this work builds on established findings.
Where this research is happening
INDIANAPOLIS, UNITED STATES
- INDIANA UNIVERSITY INDIANAPOLIS — INDIANAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RICHARDSON, TIMOTHY I — INDIANA UNIVERSITY INDIANAPOLIS
- Study coordinator: RICHARDSON, TIMOTHY I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome